Sangani Hospitals Limited IPO Review & Recommendations
Get Real-Time Updates on stock market trends and news
Get updates on stock market, Stock related news, Algo Trading, learn profitable strategies.
Join WhatsApp ChannelSangani Hospitals Limited IPO
Sangani Hospitals Limited IPO Review
Sangani Hospitals Limited IPO was engaged as a healthcare
provider that offers a variety of medical services in the Keshod and Veraval
areas of Gujarat. Their facilities have a total of 68 beds available. Their
main services encompass advanced medical care, specialized treatments, and
additional supporting services. Sangani Hospital is a medical facility with 36
beds, offering a range of specialized services. It provides different levels of
care from basic to advanced - and is conveniently situated near Keshod's bus
stand and railway station, ensuring easy access for residents of fifty-four
neighboring villages.
Sangani Hospitals Limited Products and Services
Their
Services are Healthcare providers that offer a variety of medical services. They
concentrate mainly on the healthcare sector in the state of Gujarat. They
possess a deep comprehension of how patients move within the region, their
medical needs, unique aspects, customer preferences, and the perspectives of
healthcare experts. This is a region where there's a noticeable demand for
healthcare services that are both high in quality and reasonably priced.
They
concentrate mainly on the healthcare sector in the state of Gujarat. They
possess a deep comprehension of how patients move within the region, their
medical needs, unique aspects, customer preferences, and the perspectives of
healthcare experts. This is a region where there's a noticeable demand for
healthcare services that are both high in quality and reasonably priced.
Financial Overview
The company operates within the healthcare service field, which is witnessing an increase in rivalry and is divided into many segments. Despite achieving revenue growth over the past three fiscal years, the company's profits have shown inconsistency. When looking at similar companies listed on the stock market, the comparison is not very convincing. Given the earnings in the fiscal year 2023, the offering seems to have a high price. Potential investors might want to avoid this expensive initial public offering (IPO).
0 comments